Press Releases March 24, 2026

Solana Company to Release Fourth Quarter and Full Year 2025 Operating Results on March 30, 2026

Solana Company Announces Q4 and Full Year 2025 Results Release and Conference Call

By Caleb Monroe HSDT
Solana Company to Release Fourth Quarter and Full Year 2025 Operating Results on March 30, 2026
HSDT

Solana Company, a NASDAQ-listed neurotechnology and digital asset treasury firm, will announce its fourth quarter and full year 2025 operating results on March 30, 2026, followed by a management conference call. The company combines medical device innovation with a digital asset treasury focused on holding Solana (SOL), aiming to leverage both sectors for growth.

Key Points

  • Solana Company operates in two segments: neurotechnology medical devices targeting neurologic deficits and a digital asset treasury holding Solana (SOL).
  • Q4 and full-year 2025 financial results will be released after market close on March 30, 2026, with a subsequent management discussion call.
  • The company’s partnership with Pantera Capital and Summer Capital underlines its strategy to maximize Solana (SOL) exposure and growth potential.
  • Sectors impacted include healthcare (neurotechnology and medical devices) and cryptocurrency/blockchain markets.

NEWTOWN, Pa., March 24, 2026 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”), a publicly listed company that has expanded its business to include a digital asset treasury dedicated to acquiring and holding Solana (SOL), today announced that the Company will release its fourth quarter and full year operating results on Monday, March 30, 2026, after market close.

Management will host a conference call to discuss the results and provide an expanded business update as follows:

Date:Monday, March 30, 2026Time:4:30 p.m. Eastern TimeWebcast:Click hereParticipant call link:Click here (register to receive unique PIN and dial-in number)  

The webcast will be archived under the News & Events section of the Company’s investor relations website. 

About Solana Company

Solana Company (NASDAQ: HSDT) is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. It is also a listed digital asset treasury (“DAT”) dedicated to acquiring and holding Solana (SOL). Created in partnership with Pantera Capital and Summer Capital, Solana Company’s DAT objective is to maximize SOL per share through strategic use of capital markets and on chain opportunities, offering public market investors direct exposure to Solana’s secular growth.

For more information, please visit www.solanacompany.co or follow us on X (@Solana_Company).

Media Contacts:

Solana [email protected] Capital Management [email protected] Capital [email protected]

Risks

  • Integration and execution risk in combining neurotech medical devices with a digital asset treasury business.
  • Market volatility and regulatory uncertainties impacting digital asset valuations and their effect on the company’s treasury holdings.
  • Dependence on the performance and adoption of Solana (SOL) blockchain, which could affect the company's digital asset business segment.

More from Press Releases

Yimutian Inc. Announces Resignation of Independent Director Mar 25, 2026 Rogers Communications Inc. Announces Pricing of Public Offering of US$750 million Fixed-to-Fixed Rate Subordinated Notes and Canadian Private Placement of Cdn$1.25 billion Fixed-to-Fixed Rate Subordinated Notes Mar 24, 2026 Apogee Therapeutics, Inc. Announces Pricing of $350 Million Underwritten Public Offering Mar 24, 2026 Comstock Announces Full Year 2025 Achievements and Results Mar 24, 2026 PDS Biotech Announces Conference Call and Webcast for 2025 Fourth Quarter and Year End Financial Results Mar 24, 2026